🇺🇸 FDA
Patent

US 6147060

Treatment of carcinomas using squalamine in combination with other anti-cancer agents

expired A61KA61K31/575A61K33/243

Quick answer

US patent 6147060 (Treatment of carcinomas using squalamine in combination with other anti-cancer agents) held by Magainin Pharmaceuticals Inc. expires Mon Nov 09 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Magainin Pharmaceuticals Inc.
Grant date
Tue Nov 14 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 09 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/575, A61K33/243, A61P, A61P35/00